CoreWeave has a $55.6B AI data center backlog, but build delays, surging capex, funding/dilution risk and server-life doubts ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Security defenders are girding themselves in response to the disclosure of a maximum-severity vulnerability disclosed Wednesday in React Server, an open-source package that’s widely used by websites ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Basic and Standard subscribers can stream HBO Max simultaneously on up to two devices, while Premium subscriptions up that limit to four devices. Otherwise, the main differences between plans is ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Garena Free Fire players, beware: if you are using a proxy server, be aware of the download risks! It can be riskier than you think. In many areas where Free Fire MAX is restricted, some players turn ...